---
category: news
title: "Kiromic BioPharma Pipeline to Prioritize a New Gamma Delta T-cell Product Candidate"
excerpt: "Kiromic BioPharma, Inc. (NASDAQ: KRBP), a clinical-stage biotherapeutics company using its proprietary DIAMOND AI Â® (artificial intelligence) and data mining platform to discover and develop cell therapies with a focus on immuno-oncology,"
publishedDateTime: 2022-06-21T12:17:00Z
originalUrl: "https://apnews.com/press-release/BusinessWire/technology-health-houston-artificial-intelligence-f0659ecf2c934396ae417542f15b46e6"
webUrl: "https://apnews.com/press-release/BusinessWire/technology-health-houston-artificial-intelligence-f0659ecf2c934396ae417542f15b46e6"
type: article
quality: 18
heat: 18
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "qUDeQ2nl9bNwiyA/9rdnRUue5UnSePRpW4irIaGjr6+bFFQm7UP9Ot7b+nAllg0/3qJvjCrk/Yf0GMqei25zCvMgeK5r1nTtBm9tYzd4BCsV88wJcSseOamG/Ez5kSQi4GIDd6ZmaxHNh6YSOmxi+UIQ2Afg+0baDN/4937lo0SnAzmKUUGYcXRBMMuVEF8GqR5V/Qw+Hc541hRKQQBx/cEbxgCa6Xn8cpZGI2r2OjQV7DQmR2MmNTxW5JipiXfHJD5Abn41uowfda6w5LhCgPS7/lUv7B7S8TjlKBP/2xRXpqzEfqIHJXmqCYvsQanUr23TSs5cDO/ySJE8BOp18up4Xs5VL1ikoEuTRHu5egI=;2nHCtG19qc1fFGcx4HFRQQ=="
---

